Are down-titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity possible? - A Cochrane Review summary with commentary

Giovanni Morone

doi:10.1111/1756-185X.13989

Are down-titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity possible? - A Cochrane Review summary with commentary

Fondazione Santa Lucia

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	International Journal of Rheumatic Diseases
DOIs	https://doi.org/10.1111/1756-185X.13989
Publication status	E-pub ahead of print - Nov 2020

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1111/1756-185X.13989

Cite this

@article{4fe1c6cf7d3f4906be8bb018c743312f,

title = "Are down-titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity possible? - A Cochrane Review summary with commentary",

author = "Giovanni Morone",

year = "2020",

month = nov,

doi = "10.1111/1756-185X.13989",

language = "English",

journal = "International Journal of Rheumatic Diseases",

issn = "1756-1841",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Are down-titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity possible? - A Cochrane Review summary with commentary

AU - Morone, Giovanni

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85096716279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096716279&partnerID=8YFLogxK

U2 - 10.1111/1756-185X.13989

DO - 10.1111/1756-185X.13989

M3 - Article

C2 - 33156539

AN - SCOPUS:85096716279

JO - International Journal of Rheumatic Diseases

JF - International Journal of Rheumatic Diseases

SN - 1756-1841

ER -